About Dermicus
Dermicus is a company based in Goteborg (Sweden) founded in 2010 by Daniel Eliasson and Johan Heilborn was acquired by Omda in December 2024. Dermicus offers products and services including Dermicus Telederm and Dermicus Telewound.
- Headquarter Goteborg, Sweden
- Founders Daniel Eliasson, Johan Heilborn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dermicus Ab
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dermicus
Dermicus offers a comprehensive portfolio of products and services, including Dermicus Telederm and Dermicus Telewound.
Enables remote diagnostics and collaboration for skin conditions.
Facilitates wound management and specialist consultations remotely.
People of Dermicus
Unlock access to complete
Data Analysis and Operations Team
1 people
Leadership Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Dermicus
Investors in Dermicus
Dermicus has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Omda and Almi Invest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Regulatory and security compliant software solutions are provided by Omda.
|
Locked | Locked | Locked |
Investor details for Dermicus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dermicus
Investment portfolio details for Dermicus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dermicus
Detailed financials for Dermicus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dermicus Comparisons
Peer comparison for Dermicus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dermicus
Detailed competitors of Dermicus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dermicus
Complete news archive for Dermicus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dermicus
Dermicus was founded in 2010 and raised its 1st funding round 8 years after it was founded.
Dermicus is headquartered in Goteborg, Sweden. It is registered at Goteborg, Vastra Gotaland, Sweden.
Daniel Eliasson is the current CEO of Dermicus. They have also founded this company.
Dermicus was founded in 2010 in Gothenburg, Sweden, within the healthcare technology sector. A digital platform and mobile application equipped with a dermatoscope are utilized to capture images of skin lesions. Support for diagnosing wounds, skin cancer, and other dermatological conditions is offered to physicians through these tools. Operations focus on decision-making assistance in clinical settings across Europe.
Dermicus offers Dermicus Telederm and Dermicus Telewound.
Dermicus has 2 investors. Key investors include Omda, and Almi Invest.